321 related articles for article (PubMed ID: 8453307)
1. Hemolysis of normal human erythrocytes by autologous serum complement.
Kitamura H; Nagano A; Kitano E
Int Arch Allergy Immunol; 1993; 100(3):209-14. PubMed ID: 8453307
[TBL] [Abstract][Full Text] [Related]
2. C3-independent immune haemolysis: haemolysis of EAC14oxy2 cells by C5-C9 without participation of C3.
Kitamura H; Matsumoto M; Nagaki K
Immunology; 1984 Nov; 53(3):575-82. PubMed ID: 6237987
[TBL] [Abstract][Full Text] [Related]
3. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
Rosenfeld SI; Jenkins DE; Leddy JP
J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
[TBL] [Abstract][Full Text] [Related]
4. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
Kitamura H; Tsuboi M; Nagaki K
Immunology; 1986 Jul; 58(3):459-65. PubMed ID: 3733147
[TBL] [Abstract][Full Text] [Related]
5. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
Hänsch GM; Hammer CH; Mayer MM; Shin ML
J Immunol; 1981 Sep; 127(3):999-1002. PubMed ID: 6911149
[TBL] [Abstract][Full Text] [Related]
6. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex.
Miyama A; Kato T; Horai S; Yokoo J; Kashiba S
Biken J; 1975 Dec; 18(4):193-204. PubMed ID: 1218074
[TBL] [Abstract][Full Text] [Related]
7. Activation of the complement attack mechanism in the fluid phase and its control by C567-INH: lysis of normal erythrocytes initiated by zymosan, endotoxin, and immune complexes.
Lint TF; Behrends CL; Baker PJ; Gewurz H
J Immunol; 1976 Nov; 117(5 Pt 1):1440-6. PubMed ID: 1002985
[TBL] [Abstract][Full Text] [Related]
8. C3-independent immune haemolysis: mechanism of membrane attack complex formation.
Kitamura H; Tsuboi M; Nagaki K
Immunology; 1986 Sep; 59(1):147-51. PubMed ID: 3759127
[TBL] [Abstract][Full Text] [Related]
9. C56 formation in the reaction mixture of isolated complement components through the classical complement pathway.
Kitamura H; Tsuboi M; Nagaki K
Int Arch Allergy Appl Immunol; 1985; 78(1):101-7. PubMed ID: 4030125
[TBL] [Abstract][Full Text] [Related]
10. Complement lysis of human erythrocytes. III. Differing effectiveness of human and guinea pig C9 on normal and paroxysmal nocturnal hemoglobinuria cells.
Rosenfeld SI; Packman CH; Jenkins DE; Countryman JK; Leddy JP
J Immunol; 1980 Nov; 125(5):2063-8. PubMed ID: 6776186
[No Abstract] [Full Text] [Related]
11. Enhanced complement-mediated lysis of type III paroxysmal nocturnal hemoglobinuria erythrocytes involves increased C9 binding and polymerization.
Hu VW; Nicholson-Weller A
Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5520-4. PubMed ID: 3860874
[TBL] [Abstract][Full Text] [Related]
12. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
Packman CH; Rosenfeld SI; Jenkins DE; Thiem PA; Leddy JP
J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861
[TBL] [Abstract][Full Text] [Related]
13. Deviated lysis: transfer of complement lytic activity to unsensitized cells. I. Generation of the transferable activity on the surface of complement resistant bacteria.
Rother U; Hänsch G; Menzel J; Rother K
Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):172-86. PubMed ID: 4283273
[No Abstract] [Full Text] [Related]
14. Inherited deficiencies of the late-acting complement components other than C9 found among healthy blood donors.
Inai S; Akagaki Y; Moriyama T; Fukumori Y; Yoshimura K; Ohnoki S; Yamaguchi H
Int Arch Allergy Appl Immunol; 1989; 90(3):274-9. PubMed ID: 2592116
[TBL] [Abstract][Full Text] [Related]
15. Deviated lysis: Transfer of complement lytic activity to unsensitized cells II. Generation of the activity by inulin and by antigen antibody complexes.
Rother U; Hänsch G; Rother K
Z Immunitatsforsch Immunobiol; 1976 Aug; 151(1):442-54. PubMed ID: 785847
[TBL] [Abstract][Full Text] [Related]
16. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
Joiner KA; Hammer CH; Brown EJ; Cole RJ; Frank MM
J Exp Med; 1982 Mar; 155(3):797-808. PubMed ID: 6801179
[TBL] [Abstract][Full Text] [Related]
17. Lytic activity of C5-9 complexes for erythrocytes from the species other than sheep: C9 rather than C8-dependent variation in lytic activity.
Yamamoto KI
J Immunol; 1977 Oct; 119(4):1482-5. PubMed ID: 894048
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the alternative pathway of complement activation by a serum factor generated during transplant rejection.
Spitzer R; Stitzel A; Florio L; Urmson J
Immunochemistry; 1976 May; 13(5):395-400. PubMed ID: 780264
[No Abstract] [Full Text] [Related]
19. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.
Parker CJ; Wiedmer T; Sims PJ; Rosse WF
J Clin Invest; 1985 Jun; 75(6):2074-84. PubMed ID: 4008653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
